Dr. David Alberto Iglesias, MD

Dr. Iglesias practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Iglesias' NPI, 1548335417, was assigned on November 23, 2006. Dr. Iglesias graduated from University Of Florida College Of Medicine in 2006. Dr. Iglesias holds Florida license ME161267.

Dr. Iglesias' primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Iglesias' primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iglesias practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Iglesias' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Iglesias is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Iglesias' licenses on file in 3 states: Florida, Virginia and Texas.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Iglesias treats.

CMS data shows 348 Medicare services from Dr. Iglesias across 8 procedure codes in 2024, for 98 Medicare patients. Medicare paid $17,738 for them. Every service was in an office.

CMS counts 98 Medicare patients who saw Dr. Iglesias in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iglesias' median patient age at 70, with 99% women.

In 2024, Dr. Iglesias wrote 50 Medicare Part D claims for 28 patients. 92% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $210 in total drug cost. In 2022, CMS named 48 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Iglesias for performance year 2024, reported through an alternative payment model (APM). Dr. Iglesias accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iglesias as offering telehealth. CMS counts 11 procedures of removal of the uterus by Dr. Iglesias, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Dr. Iglesias, published from 2010 to 2025. 2013 was the busiest year, with 5. The most frequent topics are Endometrial Neoplasms, Uterine Neoplasms and Carcinoma, Endometrioid. Dr. Iglesias has published most often in Gynecol Oncol. Dr. Iglesias' most frequent co-authors are Karen H. Lu, MD, Shannon Neville Westin, MD and Pamela T. Soliman, MD.

Dmand AI links Dr. Iglesias to 6 clinical trials, 5 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Ovarian Neoplasms, Ovarian Diseases and Carcinosarcoma.

CMS Open Payments shows 20 general payments to Dr. Iglesias from 5 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 45% of the total. Intuitive Surgical, Inc. paid the most, $2,063.

Dmand AI lists 4 awards for Dr. Iglesias, most recently Nell Bryant Kibler Professorship in Ovarian Cancer Research in 2023. Dr. Iglesias serves on NRG Oncology Developmental Therapeutics Committee and UF Health Cancer Center Gyn Disease Site Group.

Dr. Iglesias graduated from University Of Florida College Of Medicine in 2006. Dr. Iglesias is a member of American College of Obstetricians and Gynecologists, Felix Rutledge Society, Mid-Atlantic Gynecologic Oncology Society and Society of Gynecologic Oncology.

Dr. Iglesias is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.